FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938889417> ?p ?o ?g. }

• W2938889417 abstract "Previous research has reported that salidroside exerts antitumor properties on numerous types of tumor cells; however, its effect on osteosarcoma cells remains unknown. The present study aimed to investigate the effects of salidroside on the viability, apoptosis and invasion of osteosarcoma cells in vitro, and determine the underlying mechanism of action. The results of an MTT revealed that salidroside suppressed the viability of osteosarcoma cells (MG63 and U2OS cells) in a time‑ and concentration‑dependent manner. The results of cell morphological analysis (profile observations and Hoechst 33258 staining) and the detection of apoptosis by flow cytometry further indicated that the decrease in osteosarcoma cell viability induced by salidroside was associated with cell apoptosis. Western blot analysis not only confirmed these results but also suggested that salidroside induced the apoptosis of osteosarcoma cells by activating the caspase‑9‑dependent apoptotic pathway. In addition, we reported that salidroside induced G0/G1 phase arrest and suppressed the invasion of osteosarcoma cells, as measured by flow cytometric cell cycle analysis and a Transwell invasion assay, respectively. Western blot analysis confirmed the aforementioned results. Furthermore, our findings demonstrated that salidroside induced the apoptosis, G0/G1 phase arrest and suppressed the invasion of osteosarcoma cells by inhibiting the janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway, as determined by western blot analysis. In summary, the findings of the present study suggested that salidroside may inhibit the progression of osteosarcoma by suppressing the growth and invasion of osteosarcoma cells. Furthermore, the investigations into the underlying mechanism demonstrated that salidroside exerted notable antitumor activity in osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway." @default.
• W2938889417 created "2019-04-25" @default.
• W2938889417 creator A5006117401 @default.
• W2938889417 creator A5015205321 @default.
• W2938889417 creator A5028462736 @default.
• W2938889417 creator A5036773734 @default.
• W2938889417 creator A5040548313 @default.
• W2938889417 creator A5061819132 @default.
• W2938889417 creator A5084006425 @default.
• W2938889417 creator A5090135566 @default.
• W2938889417 date "2019-04-10" @default.
• W2938889417 modified "2023-09-23" @default.
• W2938889417 title "Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway" @default.
• W2938889417 cites W1599072427 @default.
• W2938889417 cites W1629179716 @default.
• W2938889417 cites W1706026279 @default.
• W2938889417 cites W172215053 @default.
• W2938889417 cites W181426613 @default.
• W2938889417 cites W1982623605 @default.
• W2938889417 cites W2004879716 @default.
• W2938889417 cites W2011579907 @default.
• W2938889417 cites W2018567893 @default.
• W2938889417 cites W2021922900 @default.
• W2938889417 cites W2023473357 @default.
• W2938889417 cites W2029080338 @default.
• W2938889417 cites W2030204681 @default.
• W2938889417 cites W2035519795 @default.
• W2938889417 cites W2047909392 @default.
• W2938889417 cites W2058028489 @default.
• W2938889417 cites W2060688081 @default.
• W2938889417 cites W2076824296 @default.
• W2938889417 cites W2093967541 @default.
• W2938889417 cites W2099061811 @default.
• W2938889417 cites W2122390343 @default.
• W2938889417 cites W2140151016 @default.
• W2938889417 cites W2142361364 @default.
• W2938889417 cites W2148778177 @default.
• W2938889417 cites W2179092626 @default.
• W2938889417 cites W2235574169 @default.
• W2938889417 cites W2252181372 @default.
• W2938889417 cites W2282687034 @default.
• W2938889417 cites W2412118109 @default.
• W2938889417 cites W2439901648 @default.
• W2938889417 cites W2479133488 @default.
• W2938889417 cites W2525182526 @default.
• W2938889417 cites W2534488320 @default.
• W2938889417 cites W2610706996 @default.
• W2938889417 cites W2615964030 @default.
• W2938889417 cites W2621086963 @default.
• W2938889417 cites W2749546888 @default.
• W2938889417 cites W2766488859 @default.
• W2938889417 cites W2773898096 @default.
• W2938889417 cites W2774105413 @default.
• W2938889417 cites W2781770502 @default.
• W2938889417 cites W2800201817 @default.
• W2938889417 cites W2807203113 @default.
• W2938889417 cites W79366968 @default.
• W2938889417 doi "https://doi.org/10.3892/ijo.2019.4781" @default.
• W2938889417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6521935" @default.
• W2938889417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31081055" @default.
• W2938889417 hasPublicationYear "2019" @default.
• W2938889417 type Work @default.
• W2938889417 sameAs 2938889417 @default.
• W2938889417 citedByCount "6" @default.
• W2938889417 countsByYear W29388894172020 @default.
• W2938889417 countsByYear W29388894172021 @default.
• W2938889417 countsByYear W29388894172022 @default.
• W2938889417 countsByYear W29388894172023 @default.
• W2938889417 crossrefType "journal-article" @default.
• W2938889417 hasAuthorship W2938889417A5006117401 @default.
• W2938889417 hasAuthorship W2938889417A5015205321 @default.
• W2938889417 hasAuthorship W2938889417A5028462736 @default.
• W2938889417 hasAuthorship W2938889417A5036773734 @default.
• W2938889417 hasAuthorship W2938889417A5040548313 @default.
• W2938889417 hasAuthorship W2938889417A5061819132 @default.
• W2938889417 hasAuthorship W2938889417A5084006425 @default.
• W2938889417 hasAuthorship W2938889417A5090135566 @default.
• W2938889417 hasBestOaLocation W29388894171 @default.
• W2938889417 hasConcept C104317684 @default.
• W2938889417 hasConcept C190283241 @default.
• W2938889417 hasConcept C2776415932 @default.
• W2938889417 hasConcept C2777760704 @default.
• W2938889417 hasConcept C2778923194 @default.
• W2938889417 hasConcept C2779526882 @default.
• W2938889417 hasConcept C2780783641 @default.
• W2938889417 hasConcept C29537977 @default.
• W2938889417 hasConcept C502942594 @default.
• W2938889417 hasConcept C53227056 @default.
• W2938889417 hasConcept C55493867 @default.
• W2938889417 hasConcept C62112901 @default.
• W2938889417 hasConcept C86803240 @default.
• W2938889417 hasConcept C98274493 @default.
• W2938889417 hasConceptScore W2938889417C104317684 @default.
• W2938889417 hasConceptScore W2938889417C190283241 @default.
• W2938889417 hasConceptScore W2938889417C2776415932 @default.
• W2938889417 hasConceptScore W2938889417C2777760704 @default.
• W2938889417 hasConceptScore W2938889417C2778923194 @default.
• W2938889417 hasConceptScore W2938889417C2779526882 @default.
• W2938889417 hasConceptScore W2938889417C2780783641 @default.
• W2938889417 hasConceptScore W2938889417C29537977 @default.

• next